[1]
|
[1]LIU WX, CHEN ZH, LING L, et al.Characteristics of repetitive nerve stimulation in 53 cases of amyotrophic lateral sclerosis[J].Zhonghua Yi Xue Za Zhi, 2017, 97 (29) :2297-2301.
|
[2]
|
[2]MAO Y, KUO SW, CHEN L, et al.The essential and downstream common proteins of amyotrophic lateral sclerosis:A protein-protein interaction network analysis[J].PLo S One, 2017, 12 (3) :e172246.
|
[3]
|
[3]YANG X, GAO L, WU X, et al.Increased levels of MIP-1alpha in CSF and serum of ALS[J].Acta Neurol Scand, 2016, 134 (2) :94-100.
|
[4]张叶, 刘芳, 陆荣柱.甲基汞诱导的神经毒性和凋亡[J].国外医学 (医学地理分册) , 2012, 33 (4) :280-284.
|
[5]
|
[5]CANOSA A, CALVO A, BARBERIS M, et al.Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor[J].Amyotroph Lateral Scler Frontotemporal Degener, 2015, 16 (1-2) :129-130.
|
[6]
|
[6]CHAUDHURI K R, CRUMP S, AL-SARRAJ S, et al.The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis:A clinicopathologicalstudy[J].Journal of the Neurological Sciences, 1995, 129 (129) :11-12.
|
[7]仲玲玲, 陈俊, 徐俊, 等.肌萎缩侧索硬化症患者ALSFRS-R评分与生存时间相关性分析[J].南京医科大学学报 (自然科学版) , 2011, 31 (2) :244-247.
|
[8]高丽娜.轻度ALS患者脑脊液和血清中VEGF浓度的检测及意义[D]:天津:天津医科大学硕士论文, 2015.
|
[9]杨璇.ALS患者脑脊液及血清中MIP-1α浓度的检测及意义探讨[D]:天津:天津医科大学硕士论文, 2016.
|
[10]
|
[10]FLEX A, GIOVANNINI S, BISCETTI F, et al.Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease[J].Neurodegener Dis, 2014, 13 (4) :230-236.
|
[11]
|
[11]CHAHINE LM, QIANG J, ASHBRIDGE E, et al.Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations[J].JAMA Neurol, 2013, 70 (7) :852-858.
|
[12]
|
[12]ELLISON SM, TRABALZA A, TISATO V, et al.Dose-dependent neuroprotection of VEGF (1) (6) (5) in Huntington's disease striatum[J].Mol Ther, 2013, 21 (10) :1862-1875.
|
[13]何佳, 丁凤菲, 刘敏珍, 等.VEGF/VEGFR在脑缺血再灌注损伤中的神经保护作用[J].神经损伤与功能重建, 2013, 3 (3) :177-180.
|
[14]
|
[12]GAO L, ZHOU S, CAI H, et al.VEGF levels in CSF and serum in mild ALS patients[J].J Neurol Sci, 2014, 346 (1-2) :216-220.
|
[15]
|
[13]MA YR, ZHANG S, SUN Y, et al.[MIP-1alpha promotes the migration ability of Jurkat cell through human brain microvascular endothelial cell monolayer][J].Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2014, 22 (1) :35-39.
|
[16]
|
[14]DELOACH A, COZART M, KIAEI A, et al.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies[J].Expert Opin Drug Discov, 2015, 10 (10) :1099-1118.
|
[17]
|
[15]ANAND A, GUPTA P K, SHARMA N K, et al.Soluble VEGFR1 (s VEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients[J].Eur J Neurol, 2012, 19 (5) :788-792.
|
[18]
|
[16]RUAN QF, XIE WG, WEN FP.Change in expression of vascular endothelial growth factor in serum and wound tissue of rats with electrical burns[J].Zhonghua Shao Shang Za Zhi, 2012, 28 (6) :423-427.
|